Db / db Mice Exhibit Features of Human Type 2 Diabetes That Are Not Present in Weight-Matched C57BL/6J Mice Fed a Western Diet

Journal of Diabetes Research

Volumn 2017, Issue , 2017, Pages

  Burke, Susan J ^a   Batdorf, Heidi M ^a   Burk, David H ^a   Noland, Robert C ^a   Eder, Adrianna E ^b   Boulos, Matthew S ^b   Karlstad, Michael D ^b   Jason Collier, J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; ALDH1A3 PROTEIN; CD68 ANTIGEN; CELL MARKER; CORTICOSTERONE; CRYOPYRIN; GLUCAGON; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; INTERLEUKIN 1ALPHA; LEPTIN; PATTERN RECOGNITION RECEPTOR; TRANSCRIPTION FACTOR NKX6.1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; C57BL 6 MOUSE; CELL DEDIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DB/DB MOUSE; DIET INDUCED OBESITY; GENETIC MODEL; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LOW FAT DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PROTEIN EXPRESSION; SKELETAL MUSCLE; WESTERN DIET; ANALYSIS; ANIMAL; BLOOD; BODY WEIGHT GAIN; C57BL MOUSE; COMPLICATION; DISEASE MODEL; HYPERGLYCEMIA; HYPERINSULINISM; IMMUNOLOGY; INSULIN RESISTANCE; LIVER; METABOLISM; MUTANT MOUSE STRAIN; OBESITY; PANCREAS; PANNICULITIS; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; STATISTICAL ANALYSIS;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, WESTERN; DISEASE MODELS, ANIMAL; GLUCAGON; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; LIVER; MALE; MATCHED-PAIR ANALYSIS; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OBESITY; PANCREAS; PANNICULITIS; RANDOM ALLOCATION; WEIGHT GAIN;

EID: 85029726087     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2017/8503754     Document Type: Article

References (51)

1. D. M. Muoio and C. B. Newgard, "Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes, " Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 193-205, 2008.
2. V. T. Samuel and G. I. Shulman, "Mechanisms for insulin resistance: common threads and missing links, " Cell, vol. 148, no. 5, pp. 852-871, 2012.
3. G. A. Bray, "Overweight is risking fate. Definition, classification, prevalence, and risks, " Annals of the New York Academy of Sciences, vol. 499, pp. 14-28, 1987.
4. G. A. Bray, "Obesity increases risk for diabetes, " International Journal of Obesity and Related Metabolic Disorders, vol. 16, Supplement 4, pp. S13-S17, 1992.
5. M. F. Gregor and G. S. Hotamisligil, "Inflammatory mechanisms in obesity, " Annual Review of Immunology, vol. 29, pp. 415-445, 2011.
6. J. H. Stern, J. M. Rutkowski, and P. E. Scherer, "Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk, " Cell Metabolism, vol. 23, no. 5, pp. 770-784, 2016.
7. R. H. Unger, "Lipotoxic diseases, " Annual Review of Medicine, vol. 53, pp. 319-336, 2002.
8. R. H. Unger and L. Orci, "Diseases of liporegulation: new perspective on obesity and related disorders, " The FASEB Journal, vol. 15, no. 2, pp. 312-321, 2001.
9. S. J. Burke, M. D. Karlstad, and J. J. Collier, "Pancreatic islet responses to metabolic trauma, " Shock, vol. 46, no. 3, pp. 230-238, 2016.
10. Y. Dor, J. Brown, O. I. Martinez, and D. A. Melton, "Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation, " Nature, vol. 429, no. 6987, pp. 41-46, 2004.
11. R. B. Sharma, A. C. O'Donnell, R. E. Stamateris et al., "Insulin demand regulates beta cell number via the unfolded protein response, " The Journal of Clinical Investigation, vol. 125, no. 10, pp. 3831-3846, 2015.
12. S. E. Kahn, S. Zraika, K. M. Utzschneider, and R. L. Hull, "The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality, " Diabetologia, vol. 52, no. 6, pp. 1003-1012, 2009.
13. B. B. Kahn, "Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance, " Cell, vol. 92, no. 5, pp. 593-596, 1998.
14. F. Cinti, R. Bouchi, J. Y. Kim-Muller et al., "Evidence of betacell dedifferentiation in human type 2 diabetes, " The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 3, pp. 1044-1054, 2016.
15. J. C. Schisler, P. B. Jensen, D. G. Taylor et al., "The Nkx6. 1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 20, pp. 7297-7302, 2005.
16. B. L. Taylor, F. F. Liu, and M. Sander, "Nkx6. 1 is essential for maintaining the functional state of pancreatic beta cells, " Cell Reports, vol. 4, no. 6, pp. 1262-1275, 2013.
17. R. H. Unger and L. Orci, "The essential role of glucagon in the pathogenesis of diabetes mellitus, " Lancet, vol. 1, no. 7897, pp. 14-16, 1975.
18. S. J. Burke, M. D. Karlstad, K. M. Regal et al., "CCL20 is elevated during obesity and differentially regulated by NF-kappaB subunits in pancreatic beta-cells, " Biochimica et Biophysica Acta, vol. 1849, no. 6, pp. 637-652, 2015.
19. S. J. Burke, H. M. Batdorf, A. E. Eder et al., "Oral corticosterone administration reduces insulitis but promotes insulin resistance and hyperglycemia in male nonobese diabetic mice, " The American Journal of Pathology, vol. 187, no. 3, pp. 614-626, 2017.
20. S. J. Burke, M. D. Karlstad, A. E. Eder et al., "Pancreatic betacell production of CXCR3 ligands precedes diabetes onset, " BioFactors, vol. 42, no. 6, pp. 703-715, 2016.
21. R. Klinck, P. Serup, O. D. Madsen, and M. C. Jorgensen, "Specificity of four monoclonal anti-NKx6-1 antibodies, " The Journal of Histochemistry and Cytochemistry, vol. 56, no. 4, pp. 415-424, 2008.
22. R. C. Noland, T. R. Koves, S. E. Seiler et al., "Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control, " The Journal of Biological Chemistry, vol. 284, no. 34, pp. 22840-22852, 2009.
23. T. R. Koves, J. R. Ussher, R. C. Noland et al., "Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, " Cell Metabolism, vol. 7, no. 1, pp. 45-56, 2008.
24. S. J. Burke, J. J. Collier, and D. K. Scott, "cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter, " Journal of Molecular Biology, vol. 392, no. 3, pp. 578-588, 2009.
25. D. K. Scott, J. J. Collier, T. T. Doan et al., "A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering SREBP-1c expression, " Molecular and Cellular Biochemistry, vol. 254, no. 1-2, pp. 327-337, 2003.
26. J. Purohit, P. Hu, S. J. Burke, J. J. Collier, J. Chen, and L. Zhao, "The effects of NOD activation on adipocyte differentiation, " Obesity (Silver Spring), vol. 21, no. 4, pp. 737-747, 2013.
27. M. D. Michael, R. N. Kulkarni, C. Postic et al., "Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction, " Molecular Cell, vol. 6, no. 1, pp. 87-97, 2000.
28. J. E. Galgani, C. Moro, and E. Ravussin, "Metabolic flexibility and insulin resistance, " American Journal of Physiology, Endocrinology and Metabolism, vol. 295, no. 5, pp. E1009-E1017, 2008.
29. J. P. Despres, B. Lamarche, P. Mauriege et al., "Hyperinsulinemia as an independent risk factor for ischemic heart disease, " The New England Journal of Medicine, vol. 334, no. 15, pp. 952-957, 1996.
30. B. Jeanrenaud, "Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology, " Metabolism, vol. 27, no. 12, Supplement 2, pp. 1881-1892, 1978.
31. S. M. Haffner, "Hyperinsulinemia as a possible etiology for the high prevalence of non insulin dependent diabetes in Mexican Americans, " Diabète & Métabolisme, vol. 13, no. 3, Part 2, pp. 337-344, 1987.
32. C. Crofts, G. Schofield, C. Zinn, M. Wheldon, and J. Kraft, "Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: an examination of the Kraft database, " Diabetes Research and Clinical Practice, vol. 118, pp. 50-57, 2016.
33. P. Xun, Y. Wu, Q. He, and K. He, "Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies, " The American Journal of Clinical Nutrition, vol. 98, no. 6, pp. 1543-1554, 2013.
34. K. C. Sung, M. H. Seo, E. J. Rhee, and A. M. Wilson, "Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study, " Cardiovascular Diabetology, vol. 10, p. 108, 2011.
35. O. E. Odeleye, M. de Courten, D. J. Pettitt, and E. Ravussin, "Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children, " Diabetes, vol. 46, no. 8, pp. 1341-1345, 1997.
36. A. E. Mehran, N. M. Templeman, G. S. Brigidi et al., "Hyperinsulinemia drives diet-induced obesity independently of brain insulin production, " Cell Metabolism, vol. 16, no. 6, pp. 723-737, 2012.
37. R. H. Unger, "Reinventing type 2 diabetes: pathogenesis, treatment, and prevention, " The Journal of the American Medical Association, vol. 299, no. 10, pp. 1185-1187, 2008.
38. R. Alemzadeh, M. D. Karlstad, K. Tushaus, and M. Buchholz, "Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats, " Metabolism, vol. 57, no. 11, pp. 1597-1607, 2008.
39. A. J. Stunkard, T. T. Foch, and Z. Hrubec, "A twin study of human obesity, " The Journal of the American Medical Association, vol. 256, no. 1, pp. 51-54, 1986.
40. J. C. Florez, "Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?, " Diabetologia, vol. 51, no. 7, pp. 1100-1110, 2008.
41. T. M. Frayling, J. C. Evans, M. P. Bulman et al., "Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors, " Diabetes, vol. 50, Supplement 1, pp. S94-S100, 2001.
42. S. J. Burke, K. Stadler, D. Lu et al., "IL-1beta reciprocally regulates chemokine and insulin secretion in pancreatic beta-cells via NF-kappaB, " American Journal of Physiology, Endocrinology and Metabolism, vol. 309, no. 8, pp. E715-E726, 2015.
43. R. H. Unger and A. D. Cherrington, "Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover, " The Journal of Clinical Investigation, vol. 122, no. 1, pp. 4-12, 2012.
44. P. Raskin and R. H. Unger, "Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes, " The New England Journal of Medicine, vol. 299, no. 9, pp. 433-436, 1978.
45. Y. Lee, E. D. Berglund, X. Yu et al., "Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 36, pp. 13217-13222, 2014.
46. J. Y. Kim-Muller, J. Fan, Y. J. Kim et al., "Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic beta cells in diabetic mice, " Nature Communications, vol. 7, article 12631, 2016.
47. S. P. Weisberg, D. Hunter, R. Huber et al., "CCR2 modulates inflammatory and metabolic effects of high-fat feeding, " The Journal of Clinical Investigation, vol. 116, no. 1, pp. 115-124, 2006.
48. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization, " The Journal of Clinical Investigation, vol. 117, no. 1, pp. 175-184, 2007.
49. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., "Obesity is associated with macrophage accumulation in adipose tissue, " The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796-1808, 2003.
50. P. Cohen, C. Zhao, X. Cai et al., "Selective deletion of leptin receptor in neurons leads to obesity, " The Journal of Clinical Investigation, vol. 108, no. 8, pp. 1113-1121, 2001.
51. F. P. Pralong, R. Roduit, G. Waeber et al., "Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland, " Endocrinology, vol. 139, no. 10, pp. 4264-4268, 1998.